Get the Stockscreener App
1.97
1.50%
-0.03
After Hours:
2.00
0.03
+1.52%
T 2 Biosystems Inc stock is traded at $1.97, with a volume of 84,833.
It is down -1.50% in the last 24 hours and down -38.24% over the past month.
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.
See More
Previous Close:
$2.00
Open:
$1.97
24h Volume:
84,833
Relative Volume:
0.51
Market Cap:
$34.44M
Revenue:
$7.19M
Net Income/Loss:
$-50.08M
P/E Ratio:
-0.00687
EPS:
-286.9
Net Cash Flow:
$-48.33M
1W Performance:
-4.37%
1M Performance:
-38.24%
6M Performance:
-34.33%
1Y Performance:
-91.08%
1-Day Range:
$1.95
$2.04
1-Week Range:
$1.939
$2.13
52-Week Range:
$1.939
$33.20
T 2 Biosystems Inc Stock (TTOO) Company Profile
Name
T 2 Biosystems Inc
Sector
Industry
Phone
781-457-1200
Address
101 HARTWELL AVENUE, LEXINGTON
T 2 Biosystems Inc Stock (TTOO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-21 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Nov-26-19 | Downgrade | Janney | Buy → Neutral |
| Aug-01-19 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Jul-31-19 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-31-19 | Downgrade | Janney | Buy → Neutral |
| May-16-19 | Initiated | Alliance Global Partners | Buy |
| Mar-08-19 | Reiterated | H.C. Wainwright | Buy |
| Jun-01-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| May-30-18 | Reiterated | H.C. Wainwright | Buy |
| May-29-18 | Reiterated | WBB Securities | Strong Buy |
| Mar-29-18 | Reiterated | H.C. Wainwright | Buy |
| Jan-29-18 | Initiated | Goldman | Neutral |
| Oct-18-17 | Initiated | H.C. Wainwright | Buy |
| Mar-15-17 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Nov-10-16 | Resumed | Leerink Partners | Mkt Perform |
| Nov-02-16 | Reiterated | Cantor Fitzgerald | Buy |
| Jul-20-16 | Upgrade | WBB Securities | Buy → Strong Buy |
| Jun-22-16 | Upgrade | WBB Securities | Speculative Buy → Buy |
| Apr-12-16 | Reiterated | Canaccord Genuity | Buy |
| Feb-17-16 | Initiated | WBB Securities | Speculative Buy |
View All
T 2 Biosystems Inc Stock (TTOO) Latest News
T2 Biosystems, Inc. (NASDAQ:TTOO) Short Interest Up 17.6% in September - Defense World
Armistice Capital LLC Makes New Investment in T2 Biosystems, Inc. (NASDAQ:TTOO) - Defense World
T2 Biosystems stock plunges to 52-week low of $2.01 By Investing.com - Investing.com South Africa
T2 Biosystems stock plunges to 52-week low of $2.01 - Investing.com India
T2 Biosystems stock plunges to 52-week low of $2.01 By Investing.com - Investing.com Australia
T2 Biosystems stock plunges to 52-week low of $2.01 - Investing.com
T2 Biosystems stock plunges to 52-week low of $2.01 By Investing.com - Investing.com UK
T2 Biosystems Highlights New Article Published in The Lancet: Changing the Culture of Blood Culture - GlobeNewswire
T2 Biosystems Highlights New Article Published in The Lancet: Changing the Culture of Blood Culture - StockTitan
T2 Biosystems wins patent opposition in EU - Investing.com
T2 Biosystems Achieves Successful Defense of Patent for - GlobeNewswire
T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union - StockTitan
T2 Biosystems wins patent opposition in EU - Investing.com India
T2 Biosystems director sells shares worth $133 By Investing.com - Investing.com Canada
T2 Biosystems director sells shares worth $133 - Investing.com India
T2 Biosystems stock hits 52-week low at $2.26 amid steep decline - Investing.com
T2 Biosystems director sells shares worth $133 - Investing.com
FDA approves T2 Biosystems test for pediatric sepsis - Investing.com
FDA approves T2 Biosystems test for pediatric sepsis By Investing.com - Investing.com Canada
T2 Biosystems Receives FDA Clearance to Market the T2Candida Panel for Pediatric Patients - GlobeNewswire
T2 Biosystems Receives FDA Clearance to Market the T2Candida Panel for Pediatric Patients - StockTitan
Positive Signs As Multiple Insiders Buy Rapid Micro Biosystems Stock - Yahoo Finance
T2 Biosystems stock plunges to 52-week low of $2.58 By Investing.com - Investing.com Australia
T2 Biosystems stock plunges to 52-week low of $2.58 - Investing.com
T2 Biosystems stock plunges to 52-week low of $2.58 By Investing.com - Investing.com Canada
T2 Biosystems Provides Updates on its New Product Development Pipeline Progress - ForexTV.com
T2 Biosystems: Pioneering Rapid Diagnostic Tests Launch - TipRanks
T2 Biosystems Provides Updates on its New Product Development Pipeline Progress - GlobeNewswire
T2 Biosystems Provides Updates on its New Product Development Pipeline Progress - StockTitan
T2 Biosystems (NASDAQ:TTOO) Share Price Passes Below Two Hundred Day Moving Average of $4.27 - MarketBeat
T2 Biosystems (NASDAQ:TTOO) Stock Price Crosses Below 200-Day Moving Average of $4.27 - Defense World
T2 Biosystems (NASDAQ:TTOO) Stock Quotes, Forecast and News Summary - Benzinga
T2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire
T2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
Shareholders Shouldn’t Be Too Comfortable With Microbix Biosystems' (TSE:MBX) Strong Earnings - Yahoo Finance
Balance Sheet Insights: T2 Biosystems Inc (TTOO)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
T2 Biosystems (NASDAQ:TTOO) Share Price Crosses Below 200-Day Moving Average of $4.46 - Defense World
T2 Biosystems (NASDAQ:TTOO) Share Price Crosses Below 200 Day Moving Average of $4.46 - MarketBeat
Virtu Financial LLC Has $39,000 Stock Holdings in T2 Biosystems, Inc. (NASDAQ:TTOO) - Defense World
T2 Biosystems (NASDAQ:TTOO) Stock Price Crosses Below 200 Day Moving Average of $4.49 - Defense World
A Piece Of The Puzzle Missing From Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) 32% Share Price Climb - Simply Wall St
Rapid Micro Biosystems, Inc. (RPID) Q2 2024 Earnings Call Transcript - Seeking Alpha
T2 Biosystems to Attend Upcoming Investor Conferences - StockTitan
T2 Biosystems to Attend Upcoming Investor Conferences - GlobeNewswire
T2 Biosystems (NASDAQ:TTOO) Issues Earnings Results - Defense World
T2 Biosystems (NASDAQ:TTOO) Upgraded to Sell at StockNews.com - Defense World
T2 Biosystems (NASDAQ:TTOO) Price Target Raised to $5.00 at Canaccord Genuity Group - MarketBeat
T2 Biosystems (NASDAQ:TTOO) Price Target Increased to $5.00 by Analysts at Canaccord Genuity Group - Defense World
Earnings call: T2 Biosystems reports growth amid sepsis focus - Investing.com
T2 Biosystems: Q2 Earnings Snapshot - New Haven Register
T2 Biosystems expands distribution to Malaysia, Indonesia By Investing.com - Investing.com Australia
T 2 Biosystems Inc Stock (TTOO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.62%
1.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):